triazoles has been researched along with Lymphoma in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (21.05) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Aljoundi, A; Elamin, G; Soliman, MES | 1 |
| Bajić, M; Filipović, N; Glavaš-Obrovac, L; Krstulović, L; Mišković Špoljarić, K; Rastija, V | 1 |
| Bernay, B; Betton, P; Bruder-Costa, J; Bruley, C; Callanan, MB; Combes, F; Debernardi, A; Duley, S; Emadali, A; Ferri, E; Ferro, M; Garin, J; Gressin, R; Hamaidia, S; Khochbin, S; Kieffer-Jaquinod, S; Leroux, D; McKenna, CE; Petosa, C; Rome, C; Rousseaux, S | 1 |
| Bertino, JR; Bhagavathi, S; Johnson-Farley, N; Veliz, J | 1 |
| Alexandrova, EM; Dobbelstein, M; Li, D; Lozano, G; Moll, UM; Proia, DA; Schulz, R; Xu, S; Yallowitz, AR | 1 |
| Alexander, WS; Ang, CH; Aubrey, BJ; Burns, CJ; Glaser, SP; Gong, J; Herold, MJ; Huang, DC; Kelly, GL; Khaw, SL; Roberts, AW; Segal, D; Sharp, PP; Strasser, A; Xu, Z; Yao, Y | 1 |
| Alexandrova, EM; Moll, UM; Xu, S | 1 |
| Inagaki, N; Mori, T; Yasuda, H | 1 |
| Crouse, LC; Johnson, MS; Kirby, P; Lent, EM; Reddy, G; Song, J | 1 |
| Kurumurthy, C; Narsaiah, B; Pamanji, R; Sambasiva Rao, P; Santhosh Kumar, G; Shanthan Rao, P; Veera Swamy, B; Velatooru, LR; Venkateswara Rao, J | 1 |
| Campo, M; Chaftari, AM; Hachem, RY; Jiang, Y; Kassis, C; Prince, RA; Raad, II; Ramos, E; Wang, W | 1 |
| Belitsky, G; Budunova, I; Gordon, LI; Kirsanov, K; Lesovaya, E; Popa, A; Rosen, ST; Yakubovskaya, M; Yemelyanov, A | 1 |
| Cherdyntseva, NV; Choinzonov, EL; Kagiya, TV; Kondakova, IV; Tcheredova, VV; Zagrebelnaya, GV | 1 |
| Fernández de Henestrosa, AR; García, C; Guzmán, A; Lloyd, M; Marcos, R; Marín, AP; Proudlock, RJ; Ruiz, MT; Tortajada, A | 1 |
| Feinstein, RN; Fry, RJ; Staffeldt, EF | 1 |
| Burton, E; Chengelis, CP; Gad, SC; Levin, S; Oshiro, Y; Piper, CE; Semler, DE | 1 |
| Hojo, H; Lin, KY; Torii, Y; Toyama, K; Tsuda, A; Yoshikawa, O | 1 |
| Assandri, A; Bassi, L; Filippeschi, S; Galliani, G; Mistrello, G | 1 |
| Tjälve, H | 1 |
1 trial(s) available for triazoles and Lymphoma
| Article | Year |
|---|---|
Comparison of posaconazole versus weekly amphotericin B lipid complex for the prevention of invasive fungal infections in hematopoietic stem-cell transplantation.
Topics: Administration, Oral; Adult; Aged; Amphotericin B; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Leukemia; Lipids; Lymphoma; Male; Middle Aged; Mycoses; Prospective Studies; Risk; Tacrolimus; Time Factors; Transplantation, Homologous; Triazoles | 2012 |
18 other study(ies) available for triazoles and Lymphoma
| Article | Year |
|---|---|
Co-Binding of JQ1 and Venetoclax Exhibited Synergetic Inhibitory Effect for Cancer Therapy; Potential Line of Treatment for the Waldenström Macroglobulinemia Lymphoma.
Topics: Antineoplastic Agents; Azepines; Bridged Bicyclo Compounds, Heterocyclic; Humans; Lymphoma; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Triazoles; Waldenstrom Macroglobulinemia | 2022 |
Novel 1,2,3-Triazole-Containing Quinoline-Benzimidazole Hybrids: Synthesis, Antiproliferative Activity, In Silico ADME Predictions, and Docking.
Topics: Benzimidazoles; Caco-2 Cells; Humans; Lymphoma; Molecular Docking Simulation; Quinolines; Structure-Activity Relationship; Triazoles | 2023 |
Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.
Topics: Animals; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Azepines; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Gene Silencing; Humans; Lymphoma; Lymphoma, B-Cell; Mice; Mice, SCID; Neoplasm Transplantation; Protein Structure, Tertiary; Proteomics; Rituximab; Triazoles | 2013 |
ABT-199, a BH3 mimetic that specifically targets Bcl-2, enhances the antitumor activity of chemotherapy, bortezomib and JQ1 in "double hit" lymphoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azepines; Biomimetics; Blotting, Western; Bortezomib; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Drug Synergism; Humans; Lymphoma; Peptide Fragments; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Triazoles; Tumor Cells, Cultured | 2015 |
Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment.
Topics: Alleles; Allografts; Animals; Apoptosis; Cell Line, Tumor; Disease Models, Animal; Female; Histone Deacetylase 6; Histone Deacetylases; HSP90 Heat-Shock Proteins; Humans; Lymphoma; Male; Mice; Molecular Targeted Therapy; Mutant Proteins; Neoplasm Transplantation; Protein Stability; Survival Rate; Tamoxifen; Triazoles; Tumor Suppressor Protein p53 | 2015 |
BET inhibition represses miR17-92 to drive BIM-initiated apoptosis of normal and transformed hematopoietic cells.
Topics: Animals; Apoptosis; Azepines; Bcl-2-Like Protein 11; Cell Cycle Proteins; Cell Line; Cell Line, Transformed; Disease Models, Animal; Hematopoietic System; History, Ancient; Humans; Lymphoma; Mice; Mice, Transgenic; MicroRNAs; Nuclear Proteins; RNA, Long Noncoding; Transcription Factors; Triazoles | 2016 |
Ganetespib synergizes with cyclophosphamide to improve survival of mice with autochthonous tumors in a mutant p53-dependent manner.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cyclophosphamide; Disease Models, Animal; Drug Synergism; HSP90 Heat-Shock Proteins; Lymphoma; Mice; Triazoles; Tumor Suppressor Protein p53 | 2017 |
[Case of pulmonary mycoses associated with malignant lymphoma during chemotherapy].
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Immunocompromised Host; Lung Diseases, Fungal; Lymphoma; Male; Middle Aged; Muscle Neoplasms; Prednisolone; Psoas Muscles; Pyrimidines; Treatment Outcome; Triazoles; Vincristine; Voriconazole | 2008 |
Genotoxicity assessment of an energetic propellant compound, 3-nitro-1,2,4-triazol-5-one (NTO).
Topics: Animals; Cell Line, Tumor; Cell Survival; CHO Cells; Chromosome Aberrations; Cricetinae; Cricetulus; DNA Damage; Female; Lymphoma; Male; Mice; Micronucleus Tests; Molecular Structure; Mutagenicity Tests; Mutation; Nitro Compounds; Rats; Rats, Sprague-Dawley; Reticulocytes; Risk Assessment; Risk Factors; Salmonella typhimurium; Triazoles | 2011 |
Synthesis of novel alkyltriazole tagged pyrido[2,3-d]pyrimidine derivatives and their anticancer activity.
Topics: Alkylation; Antineoplastic Agents; Azides; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Cyclization; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Leukemia, Monocytic, Acute; Lymphoma; Pyrimidines; Structure-Activity Relationship; Triazoles | 2011 |
Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.
Topics: Apoptosis; Boronic Acids; Bortezomib; Cell Line, Tumor; Dexamethasone; Dimerization; Drug Synergism; Hematologic Neoplasms; Humans; K562 Cells; Lymphoma; NF-kappa B; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proteasome Inhibitors; Pyrazines; Receptors, Glucocorticoid; RNA Interference; RNA, Small Interfering; Transcription Factor AP-1; Transcriptional Activation; Triazoles; Tumor Cells, Cultured | 2013 |
Production of nitric oxide by hypoxic radiosensitizer sanazole.
Topics: Animals; Cell Hypoxia; Lymphoma; Mastocytoma; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Nitric Oxide; Oxyhemoglobins; Radiation-Sensitizing Agents; Triazoles | 2004 |
Evaluation of the genotoxic potential of three phenyltetrahydropyridinyl butylazole-derived sigma-receptor ligand drug candidates.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Bone Marrow Cells; Cell Line, Tumor; Drug Evaluation, Preclinical; Erythroblasts; Heterocyclic Compounds, 3-Ring; Ligands; Lymphoma; Male; Maximum Tolerated Dose; Mice; Micronucleus Tests; Polycyclic Aromatic Hydrocarbons; Pyridines; Receptors, sigma; Time Factors; Triazoles | 2008 |
Carcinogenic and antitumor effects of aminotriazole on acatalasemic and normal catalase mice.
Topics: Amitrole; Animals; Antineoplastic Agents; Carcinogens; Catalase; Female; Liver Neoplasms; Lymphoma; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Triazoles | 1978 |
Promotional activities of the non-genotoxic carcinogen bemitradine (SC-33643).
Topics: Animals; Carcinogens; CHO Cells; Chromosome Aberrations; Cricetinae; Hypoxanthine Phosphoribosyltransferase; In Vitro Techniques; Liver Neoplasms, Experimental; Lymphoma; Mice; Micronucleus Tests; Mutagenicity Tests; Mutagens; Pyrimidines; Rats; Salmonella typhimurium; Triazoles | 1992 |
[A clinical evaluation of injectable fluconazole in the treatment of deep mycosis associated with hematological malignancy].
Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Drug Evaluation; Drug Tolerance; Female; Fluconazole; Humans; Injections, Intravenous; Leukemia; Lymphoma; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Triazoles | 1989 |
Immunological profile of DL111-IT, a new immunosuppressant agent.
Topics: Animals; Antibody Formation; Dose-Response Relationship, Drug; Hypersensitivity, Delayed; Immunosuppressive Agents; Inflammation; Lymphoma; Male; Neoplasms, Experimental; Rats; Rats, Inbred Strains; Triazoles | 1985 |
X-accumulation of labelled aminotriazole in some transplanted tumours in mice.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Carcinoma; Fibrosarcoma; Intestines; Kidney; Liver; Lymphoma; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Spleen; Time Factors; Transplantation, Homologous; Triazoles | 1974 |